InChI=1S/C39H49N3O8S/c1- 24- 13- 12- 16- 27- 21- 29- 36(51- 23- 32(44) 40- 29) 33(35(27) 46) 41- 31(43) 22- 28(49- 3) 17- 10- 5- 4- 6- 11- 18- 30(25(2) 34(24) 45) 50- 38(48) 39(19- 20- 39) 42- 37(47) 26- 14- 8- 7- 9- 15- 26/h4- 6,10- 11,13- 14,17,21,25,28,30,34,45- 46H,7- 9,12,15- 16,18- 20,22- 23H2,1- 3H3,(H,40,44) (H,41,43) (H,42,47) /b5- 4+,11- 6+,17- 10+,24- 13-![](images/invisible_space.gif) |
DLJPEMIJOQUTRD-KLLBSFIHSA-N |
COC1CC(=O)Nc2c(O)c(CC\C=C(C)/C(O)C(C)C(C\C=C\C=C\C=C\1)OC(=O)C1(CC1)NC(=O)C1=CCCCC1)cc1NC(=O)CSc21 |
|
Streptomyces sp.
(NCBI:txid1931)
|
of strain
TC 1190
See:
PubMed
|
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
antimicrobial agent
A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.
|
|
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
View more via ChEBI Ontology
(10E,12E,14E,20Z)- 19,26- dihydroxy- 9- methoxy- 18,20- dimethyl- 2,7- dioxo- 2,3,6,7,8,9,16,17,18,19,22,23- dodecahydro- 1H- 5,24- (metheno)[1,4]thiazino[2,3- c]azacyclotricosin- 17- yl 1- [(cyclohex- 1- en- 1- ylcarbonyl)amino]cyclopropanecarboxylate
|
(4Z,10E,12E,14E)- 6,28- Dihydroxy- 16- methoxy- 5,7- dimethyl- 18,24- dioxo- 22- thia- 19,25- diazatricyclo[18.7.1.021,26]octacosa- 1(28),4,10,12,14,20,26- heptaen- 8- yl 1- [(1- cyclohexen- 1- ylcarbonyl)amino]cyclopropanecarboxylate
|
IUPAC
|
8670557
|
Reaxys Registry Number
|
Reaxys
|
10994816
|
PubMed citation
|
Europe PMC
|
|